Herb Profile

Nigella Sativa

Nigella sativa

Nigella sativa (Black Seed) is a traditional seed extract containing thymoquinone, studied for antioxidant and immune support.

Last reviewed: •3 sources citedReport a correctionProfile-wide ·A Strong

Use extra caution — May reduce glucose, lipids, and blood pressure; monitor with antidiabetics, antihypertensives, anticoagulants, and antiplatelets. Details

Evidence
Strong Evidence
Typical onset
Varies by prep
Safety rating
Moderate caution
Best for
Metabolic, Inflammatory signaling
Avoid / review if
Pregnancy At Supplemental/High Doses, Hypoglycemia Prone Patients Without Monitoring, Known Allergy.
Next steps

Continue reading

  • If you want to browse more herbs → All herbs
Nigella Sativa monograph visual
Generated profile category visual

Safety

Safety & Cautions

May reduce glucose, lipids, and blood pressure; monitor with antidiabetics, antihypertensives, anticoagulants, and antiplatelets. GI upset or allergic rash can occur.

Elevated caution

Caution level: Elevated. One caution category applies — read it before use.

Detailed safety fields

Pregnancy, breastfeeding, and contraindications

  • Pregnancy At Supplemental/High Doses
  • Hypoglycemia Prone Patients Without Monitoring
  • Known Allergy.
  • Antidiabetics
  • Antihypertensives
  • Anticoagulants/Antiplatelets
  • Additive Metabolic Effects.

Full safety note

  • May reduce glucose, lipids, and blood pressure; monitor with antidiabetics, antihypertensives, anticoagulants, and antiplatelets. GI upset or allergic rash can occur.

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

High-Priority Caution

147 flagged pairings

Bleeding / anticoagulant risk

Moderate Caution

191 flagged pairings

Blood-sugar lowering · Blood-pressure effects

Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.

Evidence

Evidence Summary

Evidence lens

Most useful for practical interpretation when safety context also fits.

StrongStrong Evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · Metabolic Regulation · AMPK Signaling

Research maturity: Established research — Long Term Human Evidence May Be Limited.

Safety boundary: Safety note available — May reduce glucose, lipids, and blood pressure; monitor with antidiabetics, antihypertensives, anticoagulants, and antiplatelets.

This profile cites 3 human studies.

Study design details
Evidence Grade

Grade A: Strong Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Meta-analysis
Risk of Bias
Low
Consistency
Consistent
Strongest recorded design is a meta-analysis, drawn from 8 recorded studies, 5 in people. No disagreement is recorded across them.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (8)5 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

Filter by study class

Showing 8 of 8 studies.

What the evidence actually shows

This table contains 8 structured sources, including 5 human evidence sources; 0 are human trials.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

PMID 38915995

Background
Meta-analysis

Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.

—————A 2024 meta-analysis of three randomized trials (146 participants) found no significant effect on ICAM or VCAM endothelial/inflammatory markers, with severe heterogeneity. This is useful null evidence against overly broad cardiovascular-mechanism claims.PubMed →

The effect of Nigella sativa supplementation on glycemic status in adults: An updated systematic review and meta-analysis of randomized controlled trials

Background
Meta-analysis

Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.

—————A 2024 systematic review/meta-analysis of 30 randomized trials reported reductions in fasting glucose and HbA1c, but heterogeneity was high. This supports a glycemic signal with moderate caution about pooled-study variability.PubMed →

A 2025 GRADE-assessed synthesis of 82 randomized trials involving 5,026 participants reported pooled improvements across several glycemic and blood-pressure biomarkers with Nigella sativa.

Background
Meta-analysis

Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.

—————A 2025 GRADE-assessed synthesis of 82 randomized trials involving 5,026 participants reported pooled improvements across several glycemic and blood-pressure biomarkers with Nigella sativa.PubMed →

Human trial synthesis reports modest blood-pressure effects in selected populations. Preparation identity and baseline hypertensive status should remain explicit, and biomarker changes should not become cardiovascular-outcome claims.

Background
Meta-analysis

Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.

—————Human trial synthesis reports modest blood-pressure effects in selected populations. Preparation identity and baseline hypertensive status should remain explicit, and biomarker changes should not become cardiovascular-outcome claims.PubMed →

Randomized-trial synthesis reports changes in selected glycemic and cardiometabolic markers, but seed, oil, and extract preparations differ and biomarker changes do not establish diabetes treatment.

Background
Meta-analysis

Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.

—————Randomized-trial synthesis reports changes in selected glycemic and cardiometabolic markers, but seed, oil, and extract preparations differ and biomarker changes do not establish diabetes treatment.PubMed →

A review on therapeutic potential of Nigella sativa: A miracle herb

Ahmad A et al. · Asian Pac J Trop Biomed · 2013

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

——————PubMed →
Show 2 more studies

Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety

Hannan MA et al. · Nutrients · 2021

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

——————PubMed →

Nigella sativa: A Comprehensive Review of Its Therapeutic Potential, Pharmacological Properties, and Clinical Applications

Alberts A et al. · Int J Mol Sci · 2024

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

——————PubMed →

Dosing & Timing

No standardized dose
Preparation specific; use standardized product label for Preparation varies by tradition and product form and require source backed dosage review before therapeutic claims.
How Nigella Sativa works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Nigella Sativa Works

How Nigella Sativa WorksNigella Sativa acts on biological target pathways via anti inflammatory, leading to metabolic.Nigella SativaBiological TargetBiological pathwayAnti InflammatoryMetabolicObservable outcomeMetabolicRegulation
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways (preclinical)
  • Inflammatory Signaling Modulation
  • Metabolic Regulation
  • AMPK Signaling
  • NF KB Modulation
  • Nrf2 Activation
  • Glucose Metabolism Support

Active Compounds

Key constituents studied in Nigella Sativa, with full pharmacology and safety profiles.

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Sourcing options

Black Seed (Nigella sativa) product picks

Recommendation status

Product recommendations are not shown for this profile because the current site safety and monetization policy does not permit them.

Product form & quality guidelines

When sourcing Nigella Sativa, verify the label for:

  • Standardized extract: Confirm active content percentages on the supplement facts panel (e.g. standardized to specific marker compounds) rather than simple raw herb weights.
  • Third-party testing: Look for independent purity labels (USP, NSF, ConsumerLab, or Eurofins) to ensure the product is free from heavy metals, solvents, and contaminants.
  • Form bioavailability: Ensure the form matches evidence-supported configurations (e.g. standardized active extracts like bacosides, withanolides, or curcuminoids) for optimal onset and digestion tolerance.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

By Willie B. Randolph III

Founder & Head Researcher · Oak Ridge, TN · Last reviewed August 2026

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Free safety checklist

Get the Nigella Sativa research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.